Thursday, May 25, 2017
Expert Column

Expert Column

Here the industry leaders, policymakers, guiding lights from academia and sector experts present their individual or collective viewpoints on host of issues. This column is dedicated to their experiences with various aspects of  the bioscience landscape.

Chat with BioVoice

“Time ripe for Indian stem cells industry to regenerate its strength”

122
Mr B N Manohar, Chief Executive Officer, Stempeutics dismisses the claims that Indian stem cells industry hasn’t achieved much and is at the verge of fading out. Read his detailed interview with the Biovoice News.